nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—AVPR2—urine—Paget's disease of bone	0.0517	0.868	CbGeAlD
Tolvaptan—Neurological symptom—Pamidronate—Paget's disease of bone	0.0503	0.0535	CcSEcCtD
Tolvaptan—Rash generalised—Risedronate—Paget's disease of bone	0.0376	0.0399	CcSEcCtD
Tolvaptan—Hypernatraemia—Pamidronate—Paget's disease of bone	0.0289	0.0307	CcSEcCtD
Tolvaptan—Hypernatraemia—Zoledronate—Paget's disease of bone	0.0264	0.028	CcSEcCtD
Tolvaptan—Hyperkalaemia—Pamidronate—Paget's disease of bone	0.0149	0.0159	CcSEcCtD
Tolvaptan—Ecchymosis—Risedronate—Paget's disease of bone	0.0144	0.0154	CcSEcCtD
Tolvaptan—Hyperkalaemia—Zoledronate—Paget's disease of bone	0.0136	0.0145	CcSEcCtD
Tolvaptan—Asthenia—Tiludronate—Paget's disease of bone	0.0125	0.0133	CcSEcCtD
Tolvaptan—Diarrhoea—Tiludronate—Paget's disease of bone	0.0119	0.0127	CcSEcCtD
Tolvaptan—Dizziness—Tiludronate—Paget's disease of bone	0.0115	0.0122	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Pamidronate—Paget's disease of bone	0.011	0.0117	CcSEcCtD
Tolvaptan—Headache—Tiludronate—Paget's disease of bone	0.0109	0.0116	CcSEcCtD
Tolvaptan—Renal impairment—Zoledronate—Paget's disease of bone	0.0106	0.0112	CcSEcCtD
Tolvaptan—Thirst—Zoledronate—Paget's disease of bone	0.0106	0.0112	CcSEcCtD
Tolvaptan—Breast disorder—Risedronate—Paget's disease of bone	0.0105	0.0111	CcSEcCtD
Tolvaptan—Nausea—Tiludronate—Paget's disease of bone	0.0103	0.011	CcSEcCtD
Tolvaptan—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.0103	0.011	CcSEcCtD
Tolvaptan—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00943	0.01	CcSEcCtD
Tolvaptan—Dehydration—Zoledronate—Paget's disease of bone	0.00936	0.00995	CcSEcCtD
Tolvaptan—Discomfort—Etidronic acid—Paget's disease of bone	0.00859	0.00913	CcSEcCtD
Tolvaptan—Dysgeusia—Alendronate—Paget's disease of bone	0.00852	0.00906	CcSEcCtD
Tolvaptan—Renal failure—Pamidronate—Paget's disease of bone	0.00835	0.00888	CcSEcCtD
Tolvaptan—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00807	0.00858	CcSEcCtD
Tolvaptan—Pollakiuria—Zoledronate—Paget's disease of bone	0.00804	0.00855	CcSEcCtD
Tolvaptan—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00792	0.00842	CcSEcCtD
Tolvaptan—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00788	0.00838	CcSEcCtD
Tolvaptan—CYP3A4—urine—Paget's disease of bone	0.00787	0.132	CbGeAlD
Tolvaptan—Urethral disorder—Risedronate—Paget's disease of bone	0.00786	0.00836	CcSEcCtD
Tolvaptan—Malaise—Alendronate—Paget's disease of bone	0.00785	0.00834	CcSEcCtD
Tolvaptan—Renal failure—Zoledronate—Paget's disease of bone	0.00763	0.00811	CcSEcCtD
Tolvaptan—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00753	0.00801	CcSEcCtD
Tolvaptan—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00749	0.00797	CcSEcCtD
Tolvaptan—Urethral disorder—Pamidronate—Paget's disease of bone	0.00747	0.00795	CcSEcCtD
Tolvaptan—Cardiac disorder—Risedronate—Paget's disease of bone	0.00744	0.00791	CcSEcCtD
Tolvaptan—Discomfort—Alendronate—Paget's disease of bone	0.00732	0.00778	CcSEcCtD
Tolvaptan—Angiopathy—Risedronate—Paget's disease of bone	0.00728	0.00774	CcSEcCtD
Tolvaptan—Immune system disorder—Risedronate—Paget's disease of bone	0.00724	0.0077	CcSEcCtD
Tolvaptan—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00723	0.00769	CcSEcCtD
Tolvaptan—Constipation—Etidronic acid—Paget's disease of bone	0.00713	0.00758	CcSEcCtD
Tolvaptan—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00708	0.00752	CcSEcCtD
Tolvaptan—Malnutrition—Risedronate—Paget's disease of bone	0.00698	0.00742	CcSEcCtD
Tolvaptan—Angiopathy—Pamidronate—Paget's disease of bone	0.00692	0.00736	CcSEcCtD
Tolvaptan—Immune system disorder—Pamidronate—Paget's disease of bone	0.00689	0.00732	CcSEcCtD
Tolvaptan—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00688	0.00731	CcSEcCtD
Tolvaptan—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00687	0.00731	CcSEcCtD
Tolvaptan—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00687	0.0073	CcSEcCtD
Tolvaptan—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00684	0.00728	CcSEcCtD
Tolvaptan—Urethral disorder—Zoledronate—Paget's disease of bone	0.00683	0.00726	CcSEcCtD
Tolvaptan—Malnutrition—Pamidronate—Paget's disease of bone	0.00664	0.00706	CcSEcCtD
Tolvaptan—Dysgeusia—Pamidronate—Paget's disease of bone	0.0065	0.00691	CcSEcCtD
Tolvaptan—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00646	0.00687	CcSEcCtD
Tolvaptan—Angiopathy—Zoledronate—Paget's disease of bone	0.00632	0.00672	CcSEcCtD
Tolvaptan—Immune system disorder—Zoledronate—Paget's disease of bone	0.00629	0.00669	CcSEcCtD
Tolvaptan—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00628	0.00667	CcSEcCtD
Tolvaptan—Syncope—Risedronate—Paget's disease of bone	0.00626	0.00666	CcSEcCtD
Tolvaptan—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00616	0.00655	CcSEcCtD
Tolvaptan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00614	0.00653	CcSEcCtD
Tolvaptan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00614	0.00652	CcSEcCtD
Tolvaptan—Constipation—Alendronate—Paget's disease of bone	0.00607	0.00646	CcSEcCtD
Tolvaptan—Malnutrition—Zoledronate—Paget's disease of bone	0.00606	0.00645	CcSEcCtD
Tolvaptan—Malaise—Pamidronate—Paget's disease of bone	0.00598	0.00636	CcSEcCtD
Tolvaptan—Syncope—Pamidronate—Paget's disease of bone	0.00595	0.00633	CcSEcCtD
Tolvaptan—Dysgeusia—Zoledronate—Paget's disease of bone	0.00594	0.00631	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.0059	0.00628	CcSEcCtD
Tolvaptan—Pruritus—Etidronic acid—Paget's disease of bone	0.0059	0.00627	CcSEcCtD
Tolvaptan—Feeling abnormal—Alendronate—Paget's disease of bone	0.00585	0.00622	CcSEcCtD
Tolvaptan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00583	0.0062	CcSEcCtD
Tolvaptan—Dry mouth—Risedronate—Paget's disease of bone	0.00581	0.00618	CcSEcCtD
Tolvaptan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.0057	0.00606	CcSEcCtD
Tolvaptan—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00562	0.00598	CcSEcCtD
Tolvaptan—Body temperature increased—Alendronate—Paget's disease of bone	0.00561	0.00597	CcSEcCtD
Tolvaptan—Shock—Risedronate—Paget's disease of bone	0.00561	0.00596	CcSEcCtD
Tolvaptan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00559	0.00594	CcSEcCtD
Tolvaptan—Discomfort—Pamidronate—Paget's disease of bone	0.00558	0.00594	CcSEcCtD
Tolvaptan—Skin disorder—Risedronate—Paget's disease of bone	0.00553	0.00589	CcSEcCtD
Tolvaptan—Malaise—Zoledronate—Paget's disease of bone	0.00547	0.00581	CcSEcCtD
Tolvaptan—Syncope—Zoledronate—Paget's disease of bone	0.00544	0.00578	CcSEcCtD
Tolvaptan—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00542	0.00576	CcSEcCtD
Tolvaptan—Shock—Pamidronate—Paget's disease of bone	0.00533	0.00567	CcSEcCtD
Tolvaptan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00533	0.00567	CcSEcCtD
Tolvaptan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00531	0.00565	CcSEcCtD
Tolvaptan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00523	0.00556	CcSEcCtD
Tolvaptan—Headache—Etidronic acid—Paget's disease of bone	0.00522	0.00555	CcSEcCtD
Tolvaptan—Anorexia—Pamidronate—Paget's disease of bone	0.00516	0.00549	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00513	0.00545	CcSEcCtD
Tolvaptan—Discomfort—Zoledronate—Paget's disease of bone	0.0051	0.00542	CcSEcCtD
Tolvaptan—Asthenia—Alendronate—Paget's disease of bone	0.00509	0.00542	CcSEcCtD
Tolvaptan—Dry mouth—Zoledronate—Paget's disease of bone	0.00505	0.00537	CcSEcCtD
Tolvaptan—Pruritus—Alendronate—Paget's disease of bone	0.00502	0.00534	CcSEcCtD
Tolvaptan—Nausea—Etidronic acid—Paget's disease of bone	0.00495	0.00526	CcSEcCtD
Tolvaptan—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00495	0.00526	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00492	0.00523	CcSEcCtD
Tolvaptan—Constipation—Risedronate—Paget's disease of bone	0.00487	0.00518	CcSEcCtD
Tolvaptan—Shock—Zoledronate—Paget's disease of bone	0.00487	0.00518	CcSEcCtD
Tolvaptan—Diarrhoea—Alendronate—Paget's disease of bone	0.00486	0.00517	CcSEcCtD
Tolvaptan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00485	0.00516	CcSEcCtD
Tolvaptan—Skin disorder—Zoledronate—Paget's disease of bone	0.00481	0.00511	CcSEcCtD
Tolvaptan—Anorexia—Zoledronate—Paget's disease of bone	0.00472	0.00501	CcSEcCtD
Tolvaptan—Decreased appetite—Pamidronate—Paget's disease of bone	0.00471	0.00501	CcSEcCtD
Tolvaptan—Dizziness—Alendronate—Paget's disease of bone	0.0047	0.00499	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00468	0.00497	CcSEcCtD
Tolvaptan—Constipation—Pamidronate—Paget's disease of bone	0.00463	0.00493	CcSEcCtD
Tolvaptan—Body temperature increased—Risedronate—Paget's disease of bone	0.0045	0.00479	CcSEcCtD
Tolvaptan—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00446	0.00475	CcSEcCtD
Tolvaptan—Headache—Alendronate—Paget's disease of bone	0.00445	0.00473	CcSEcCtD
Tolvaptan—Decreased appetite—Zoledronate—Paget's disease of bone	0.0043	0.00457	CcSEcCtD
Tolvaptan—Body temperature increased—Pamidronate—Paget's disease of bone	0.00428	0.00455	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00427	0.00454	CcSEcCtD
Tolvaptan—Constipation—Zoledronate—Paget's disease of bone	0.00423	0.0045	CcSEcCtD
Tolvaptan—Nausea—Alendronate—Paget's disease of bone	0.00422	0.00449	CcSEcCtD
Tolvaptan—Hypersensitivity—Risedronate—Paget's disease of bone	0.0042	0.00446	CcSEcCtD
Tolvaptan—Asthenia—Risedronate—Paget's disease of bone	0.00409	0.00435	CcSEcCtD
Tolvaptan—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00408	0.00434	CcSEcCtD
Tolvaptan—Pruritus—Risedronate—Paget's disease of bone	0.00403	0.00429	CcSEcCtD
Tolvaptan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00399	0.00424	CcSEcCtD
Tolvaptan—Body temperature increased—Zoledronate—Paget's disease of bone	0.00391	0.00416	CcSEcCtD
Tolvaptan—Diarrhoea—Risedronate—Paget's disease of bone	0.0039	0.00415	CcSEcCtD
Tolvaptan—Asthenia—Pamidronate—Paget's disease of bone	0.00389	0.00413	CcSEcCtD
Tolvaptan—Pruritus—Pamidronate—Paget's disease of bone	0.00383	0.00407	CcSEcCtD
Tolvaptan—Dizziness—Risedronate—Paget's disease of bone	0.00377	0.00401	CcSEcCtD
Tolvaptan—Diarrhoea—Pamidronate—Paget's disease of bone	0.00371	0.00394	CcSEcCtD
Tolvaptan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00365	0.00388	CcSEcCtD
Tolvaptan—Dizziness—Pamidronate—Paget's disease of bone	0.00358	0.00381	CcSEcCtD
Tolvaptan—Headache—Risedronate—Paget's disease of bone	0.00357	0.0038	CcSEcCtD
Tolvaptan—Asthenia—Zoledronate—Paget's disease of bone	0.00355	0.00377	CcSEcCtD
Tolvaptan—Pruritus—Zoledronate—Paget's disease of bone	0.0035	0.00372	CcSEcCtD
Tolvaptan—Headache—Pamidronate—Paget's disease of bone	0.00339	0.00361	CcSEcCtD
Tolvaptan—Diarrhoea—Zoledronate—Paget's disease of bone	0.00339	0.0036	CcSEcCtD
Tolvaptan—Nausea—Risedronate—Paget's disease of bone	0.00338	0.0036	CcSEcCtD
Tolvaptan—Dizziness—Zoledronate—Paget's disease of bone	0.00327	0.00348	CcSEcCtD
Tolvaptan—Nausea—Pamidronate—Paget's disease of bone	0.00322	0.00342	CcSEcCtD
Tolvaptan—Headache—Zoledronate—Paget's disease of bone	0.0031	0.0033	CcSEcCtD
Tolvaptan—Nausea—Zoledronate—Paget's disease of bone	0.00294	0.00312	CcSEcCtD
